首页> 外文期刊>American Journal of Physiology >Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.
【24h】

Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.

机译:人类表面活性剂蛋白A1(SP-A1)基因特异性抗体的表征;不同年龄和肺部健康的个体之间SP-A1含量的差异。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The human surfactant protein A (SP-A) locus consists of two functional genes (SP-A1, SP-A2) with gene-specific products exhibiting qualitative and quantitative differences. The aim here was twofold: 1) generate SP-A1 gene-specific antibody, and 2) use this to assess gene-specific SP-A content in the bronchoalveolar lavage fluid (BALF). An SP-A1-specific polyclonal antibody (hSP-A1_Ab(68-88)_Col) was raised in chicken, and its specificity was determined by immunoblot and ELISA using mammalian Chinese hamster ovary (CHO) cell-expressed SP-A1 and SP-A2 variants and by immunofluorescence with stably transfected CHO cell lines expressing SP-A1 or SP-A2 variants. SP-A1 content was evaluated according to age and lung status. A gradual decrease (P < 0.05) in SP-A1/SP-A ratio was observed in healthy subjects (HS) with increased age, although no significant change was observed in total SP-A content among age groups. Total SP-A and SP-A1 content differed significantly between alveolar proteinosis (AP) patients and HS, with no significant difference observed in SP-A1/SP-A ratio between AP and HS. The cystic fibrosis (CF) ratio was significantly higher compared with AP, HS, and noncystic fibrosis (NCF), even though SP-A1 and total SP-A were decreased in CF compared with most of the other groups. The ratio was higher in culture-positive vs. culture-negative samples from CF and NCF (P = 0.031). A trend of an increased ratio was observed in culture-positive CF (0.590 +/- 0.10) compared with culture-positive NCF (0.368 +/- 0.085). In summary, we developed and characterized an SP-A1 gene-specific antibody and used it to identify gene-specific SP-A content in BALFs as a function of age and lung health.
机译:人表面活性剂蛋白A(SP-A)基因座由两个功能基因(SP-A1,SP-A2)组成,这些基因具有特定的产物,在质和量上均表现出差异。这里的目的是双重的:1)生成SP-A1基因特异性抗体,和2)用它来评估支气管肺泡灌洗液(BALF)中基因特异性SP-A的含量。产生了SP-A1特异的多克隆抗体(hSP-A1_Ab(68-88)_Col),并使用哺乳动物中国仓鼠卵巢(CHO)细胞表达的SP-A1和SP- A2变体,并通过稳定的转染表达SP-A1或SP-A2变体的CHO细胞系进行免疫荧光检测。根据年龄和肺部状态评估SP-A1含量。在健康受试者(HS)中,随着年龄的增长,SP-A1 / SP-A的比例逐渐降低(P <0.05),尽管各年龄组的总SP-A含量未见明显变化。肺泡蛋白沉着症(AP)患者和HS之间的总SP-A和SP-A1含量存在显着差异,而AP和HS之间的SP-A1 / SP-A比值没有显着差异。囊性纤维化(CF)的比率明显高于AP,HS和非囊性纤维化(NCF),尽管与其他大多数组相比,CF中的SP-A1和总SP-A降低了。来自CF和NCF的培养阳性样品与培养阴性样品的比例更高(P = 0.031)。与培养阳性NCF(0.368 +/- 0.085)相比,培养阳性CF(0.590 +/- 0.10)中观察到比率增加的趋势。总而言之,我们开发并鉴定了SP-A1基因特异性抗体,并将其用于鉴定BALF中基因特异性SP-A含量与年龄和肺部健康的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号